Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction

BACKGROUND: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Up to 20%–30% of patients hospitalized with COVID-19 have evidence of cardiac dysfunction. Xuebijing injection is a compound injection containing...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ding-Dong, Zhang, Xiao-Kang, Zhu, Xin-Yu, Huang, Fang-Fang, Wang, Zi, Tu, Jian-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899014/
https://www.ncbi.nlm.nih.gov/pubmed/33662681
http://dx.doi.org/10.1016/j.compbiomed.2021.104293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899014/
https://www.ncbi.nlm.nih.gov/pubmed/33662681
http://dx.doi.org/10.1016/j.compbiomed.2021.104293

Ejemplares similares